"Pharmaceutical companies have changed the targeting of their sales activities towards specialists and reduced the total number of sales representatives."
In Conversation
"The interaction with high public officials is difficult. So we try to do all our work in the field."
"In terms of life science, we have begun to invest in niche products, for example nuclear medicine. Not many companies are involved in radioactive products, and…
"Swiss culture is generally tuned towards innovation and quality, and Switzerland is ranked the most innovative country in Europe and the world by many indexes. This mentality very…
"The decision to contract research activities to a CRO is typically driven by both the quality that the sponsor will receive and the cost-saving prospect of…
"We are directly engaged with more British businesses than ever before and therefore, Brexit in the context of business, is widening the scope of opportunities for…
"One of the main risks that a distributor faces is the possibility that the multinational companies that they represent open a subsidiary in the country once…
"For all of our products, the efficacy is driven by the optimal combination and formulation of extracts of different herbs, flowers, roots and barks, which when…
"The medtech industry, as a group of people, are at a higher pitch in terms of the degree of change they have to go through."
"Over the last few years, there have been waves of innovations introduced to the diabetes market by both Novo Nordisk and other innovators."
"In the mid term, we want to deepen our collaboration with our US and Japan-based commercial partners and get more largely involved in the marketing and…
"In the mid term, we want to deepen our collaboration with our US and Japan-based commercial partners and get more largely involved in the marketing and…
